Dry Powder Inhaler
AssigneeMannKind Corporation
InventorsP. Spencer Kinsey, Brendan Laurenzi, Chad C. Smutney, Benoit Adamo, Joseph Guarneri
Life of this patent
Estimating the term…
Abstract
A dry powder inhaler including replaceable cartridges containing a dry powder for local or systemic delivery through the pulmonary tract and lungs is disclosed. The inhalers are used with inhalable dry powders, including medicament formulations comprising active agents for local or systemic delivery and for the treatment of diseases such as, pulmonary hypertension, cardiovascular disease, anaphylaxis, diabetes, obesity, cancer, and other diseases, or symptoms associated with these and other diseases, such as nausea, vomiting, pain and inflammation.
Claims20
A dry powder inhaler comprising:
- a housing, and
- a body comprising a mouthpiece integrally configured with the body,
- wherein the body comprises a mounting area for a cartridge, and the body and the housing are movable relative to one another linearly and are operably configured to engage one another by insertion to effectuate the cartridge to be reconfigured to attain an airflow pathway for discharging a powder dose upon an inhalation.
A dry powder inhaler comprising a body, a housing, a cartridge and a mouthpiece, said body having a mounting area for said cartridge and said cartridge comprising a dry powder composition comprising microcrystalline particles of fumaryl diketopiperazine and a drug, and wherein said housing translationally glides over said body in a proximal to distal direction to open the inhaler, or from distal to proximal direction to close the inhaler, wherein when the inhaler is closed the inhaler has one or more rigid air conduits for dispensing the dry powder.
Dependencies are inferred from the claim text.